Presentation is loading. Please wait.

Presentation is loading. Please wait.

Presented by: Dr. Letshufi DSV 04th August 2016 Pretoria

Similar presentations


Presentation on theme: "Presented by: Dr. Letshufi DSV 04th August 2016 Pretoria"— Presentation transcript:

1 Presented by: Dr. Letshufi DSV 04th August 2016 Pretoria
Case Study Presented by: Dr. Letshufi DSV 04th August 2016 Pretoria

2 Linda Referred by district hospital with history
38 years old with two children 10 yrs. & 4years) Referred by district hospital with history Cough, productive for 1/12 Steady weight loss Night sweat No previous history of TB Younger sister had MDR TB RVD reactive on HAART for 2 years. Fixed dose combination tablets. GXP: Rifampicin resistant TB 20 June 2014.

3 Questions Which confirmatory test is to be done?
Blood tests to be done prior initiation of therapy? Construct a regimen for this patient? What adjustment would you make on the ARV Regimen and why? Name the monthly test to be done for monitoring?

4 Questions Conti……… What is culture conversion and how is it determined ? Would you change your regimen based on LPA no - 2 and why? Which drug is stopped if patient develops profound hearing loss ? What is the diagnosis according to drug sensitivity testing ? What is the approach to the two children ?

5 LINDA FOLLOW UP H – Resistant Mutation Kat G and inh A
1. LPA R – Resistant H – Resistant Mutation Kat G and inh A 2. LPA : R - Sensitive H – Sensitive 3. Culture Negative 4. Culture Negative 5. Drug Sensitivity Testing Rifampicin - resistant Ofloxacin - Resistant Isoniazid Negative Kanamycin – Sensitive 6. Culture Negative

6 Any questions

7 Thank you


Download ppt "Presented by: Dr. Letshufi DSV 04th August 2016 Pretoria"

Similar presentations


Ads by Google